deltatrials
Unknown PHASE4 NCT00708539

A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

Sponsor: Merck Serono International SA

Conditions IVF - Luteal Phase Support After Embryo Transfer
Interventions Progesterone progesterone
Updated 7 times since 2017 Last updated: Jul 1, 2008 Started: Apr 30, 2006 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

Listed as NCT00708539, this PHASE4 trial focuses on IVF - Luteal Phase Support After Embryo Transfer and remains ongoing. Sponsored by Merck Serono International SA, it has been updated 7 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

  2. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE4

    First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck Serono International SA
  • Nordica Fertility Clinic
Data source: Nordica Fertility Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark, Brædstrup, Denmark, Dronninglund, Denmark, Frederiksberg, Denmark, Gothenburg, Sweden, Herlev, Denmark, Holbæk, Denmark, Huddinge, Sweden, Hvidovre, Denmark, København Ø, Denmark and 6 more location s